Top

Our Expertise

shutterstock_331204613 (1).jpg
 

Therapeutic Expertise

As a trusted partner on your clinical program, AMS is committed to providing you with a global clinical team who will actively guide your submissions, trial, interact professionally with sites, build key opinion leader relationships, all the while, providing positive engagement in your project.

 
 

Image Oncology

Full-service oncology clinical trial expertise offering the right data, on time & on budget.

Oncology Strategy  

One of our key areas of expertise is supporting oncology studies in Phase I-IV trials with extensive experience navigating the complexity of hematology and solid tumor compounds to the latest targeted therapies and companion diagnostics in oncology trials. 

Read More

We cover the spectrum of hematological and solid tumor therapeutic indications from small dose finding studies to larger global trials. 

Our dedicated team of experts successfully supports our clients in the rapidly growing field of immuno-oncology (IO). We have in-depth knowledge of major strategies in IO clinical trials, including:

  • Checkpoint inhibitors,

  • CAR-T

  • Anti-PD1

  • Anti-PDL1 and combination studies

Our strong regulatory team will navigate you through your global oncology strategy, while our team of oncology experts will introduce you to leading investigators through our in-depth relationships globally. 

Patient Recruitment 

Patient recruitment is always critical in this highly competitive therapeutic area. AMS has relationships with patient advocate groups, can help source patients and streamline your clinical design

Read More

We are always innovating clinical solutions in terms of site management to ensure investigator engagement by providing site MSLs or educators, specifically when you have complex schedules of assessments. 

 

Oncology Indications & Treatment Modalities

We have conducted our services across a broad range of oncology indications and treatment modalities. Read more to find out our areas of specialty within a solid and hematological tumors.

Read More

Solid Tumors

  • Actinic Keratosis

  • Bladder Cancer

  • Breast Cancer

  • CIN II – III Cervical Cancer

  • Colon Cancer

  • Gastro-intestinal

  • Melanoma

  • Pancreatic Cancer

  • Gastric Cancer

  • Prostate Cancer

  • Lung Cancer (Small Cell Lung Cancer and NSCLC)

  • Urothel Carcinoma

Hematological Tumors

  • ALCL

  • B-ALL

  • B-CLL Leukemia

  • CLL Leukemia

  • CNS Lymphoma

  • Hodgkin Lymphoma

  • High Grade Non-Hodgkin’s Lymphoma

  • Mantle Cell Lymphoma

  • Multiple Myeloma

  • T-Cell Acute Leukemia (T-ALL)

  • T-Cell Lymphoma (CTCL)

  • Hematological Malignancies (ALL, AML, CML, MDS, MPD, ALL, CLL, NHL)

  • Lymphoma (DLBCL & Follicular NHL)

 
 
 

Image Rare & Orphan Disease

Your clinical trial enrollment and site selection experts.

We Help Pioneer the Way

Most rare diseases have no cure, yet. Our goal at AMS is to help pioneer transformative medicines for patients with rare and orphan diseases. Rare disease trials and programs can be complex in nature, that’s why you need an experienced team. 

Read More

AMS has the:

  • Regulatory acumen

  • Ability to harness strong investigator relationships

  • Partners with advocacy groups

  • Focuses on recruiting the right patient in the right location

Varied and Expansive

We have worked on 90 rare disease trials in oncology, rheumatology, endocrinology, immunology, GI and orthopedic spaces. Learn more about some of the disorders we've worked on.

Read More

A small snapshot of some disorders we’ve worked on: 

  • Strong focus in HAE

  • Strong focus in Hemophilia

  • aTTp

  • Hematological disorders

  • HPN

  • Cushing’s Syndrome

  • Rare Cancer Disorders

  • Hypogonadism

  • Endocrinology Disorders: Growth Disorders

  • Urea Cycle Disorders

  • Acromegaly

  • Metabolic Syndrome

 

Every Patient Matters

Our experts will create innovative strategies and solutions for each unique requirement for your study. We work with you and guide you through tactical implementation to provide high-integrity data and ensure timely completion. 

 
 
053066.png
 
 

 After 21 years of experience in this industry, AMS has proudly completed over 570 trials across all phases of development and several complex indications.

 
 
Image #24.jpg
 

Image Neurology

Delivering streamlined clinical research solutions to complex neurology trials.

Unique and Innovative Strategies 

The landscape for diagnosis and treatment of neurological disorders is rapidly changing and so are the respective clinical trials. We have developed our own unique and innovative strategies and tools to solve problems and keep your neurology study on track. 

Read More

Our senior neurology focused physicians, project managers and CRAs are specialists in neurology clinical research. 

Neurology Studies

Neurology studies are complex. AMS will manage the many assessments associated with each trial. Read more to find out how we can help manage your study.

Read More

  • Patient self-assessment scales

  • Inter-rater reliability

  • Investigator Interactions

  • Placebo Response Analysis

  • Ensuring standardization in neuro-imaging techniques

Our experience with neuroscience trials includes access to a unique set of treatment centers with readily accessible patient populations. 

 

Neurology Indications & Treatment Modalities 

We have conducted our services across a broad range of neurological indications and treatment modalities. Read more to find out our areas of specialty.

Read More

  • Multiple Sclerosis

  • Parkinson’s Disease

  • Alzheimer’s Disease

  • Vascular Dementia

  • Epilepsy

  • Vertigo

  • Sleep disturbance

  • Migraine

  • Peripheral Neuropathy

  • Dupuytren’s Contracture

  • Encephalitis

  • Depression

  • Pain

  • Alzheimer’s Disease

  • Other psychiatric diseases

 
 
053066.png
 

Image Late-Phase Post Authorization Studies

AMS has the strength and depth of expertise in this market space.

We’ll Guide You the Entire Way

In order to demonstrate the superiority versus competitive products, obtain approval in new indications or in new patient populations, or to gain more real-world evidence for formulary success, we have the strength and depth of expertise in this market space.

Read More

AMS implements:

  • Centralized systems and processes

  • Dedicated and experienced project teams

  • Maximizes site relationships to ensure your post approval trial has a successful outcome

We Have the Necessary Tools

Our team has designed the necessary tools to help you. We’ve developed innovative tools, such as full validated GDPR compliant patient reported outcome solutions with our AMS-ePRO®. Learn more about our areas of expertise.

Read More

Our areas of expertise: 

  • Phase IV

  • PMOs

  • PRO validation studies

  • Participation satisfaction surveys

  • RWE

  • Health Economic Studies

  • Retrospective/Prospective Chart Review

  • Registries

  • Database Analysis

  • Epidemiological Surveys

  • Oncology

  • Neurology

  • Endocrinology

  • Immunology

  • Rare Disease

We Ensure High-Quality

AMS recognizes that Phase IV and post authorization studies are not clones of your Phase III studies. Different approaches are required. We have extensive experience in late phase studies to ensure you still receive high quality data within tight timelines and limited budgets. 

 
 
 

Image Endocrinology & Metabolism

Navigating and leading the way in clinical research studies in metabolic diseases.

Therapeutic Experience & Strategies 

Our therapeutic experience in chronic metabolic and endocrine disorders is unsurpassed by other CROs. Learn more about how our operational staff have a proven track of how to best manage your study.

Read More

Our operational staff have a proven track record of:

  • Rapid study start-up

  • Successful recruitment and retention

  • High-quality site monitoring and oversight

  • Proactive risk mitigation

For our most challenging clinical trials, we facilitate collaborations with academic research organizations to determine the best strategy. 

Indications

We have conducted our services across a broad range of endocrinology and metabolism indications. Learn more about our areas of expertise.

Read More

  • Strong focus in Diabetes

  • HRT

  • Gout

  • Obesity

  • Metabolic syndrome

  • Growth disorders

  • Dyslipidemia

  • Dyspepsia

  • Strong focus in Irritable Bowel Syndrome (IBS)

  • Acromegaly

  • Urea Cycle Disorders

  • Hypogonadism

 

Clinical Trials 

We have conducted a large number of endocrine and metabolic clinical trials globally, including in emerging markets. Our team of in-house experts have made significant contributions to numerous NDA submissions. We have access to a large network of patients and clinicians that help overcome patient recruitment challenges. 

 
 
Screen Shot 2019-10-20 at 12.57.28 PM.png
 

Image Other Areas of Therapeutic Expertise

At AMS, we have a network of experienced team members who are up-to-date with the latest developments in over a dozen therapeutic areas.

We Partner With You

We partner with you to implement the most target leading trial design to obtain the most consistent and reproducible results so we can provide you with robust clinical data within the expected time range. 

Therapeutic Indications

Our depth of experience across multiple therapeutic indications is wide and varied. Click ‘read more’ to expand the list.

Read More

  • Infectious Disease

  • Immunology

  • Medical Device

  • Diagnostics

  • Wound Care

  • Ophtalmology

 
 

Get in touch.

Have questions or comments?
Contact an AMS team member.